Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
Healthcare
$27.69 +1.77%
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
52W Low $24.15High $32.23
Volume 0.40M
Average 0.51M
AVLN Total Debt
Short-term and long-term borrowings combined.
No reported Total Debt figures are available to summarize.
Total Debt history
Currency unavailable · from the balance sheet
No Total Debt data reported for this period type.
Total Debt vs competitors
How AVLN compares with its peers on the latest reported figures
AVLN Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $579.88M USD | -22.0% | -13.3% | 27.6% | |
| Mar 2026 | $436.67M USD | +824.2% | +18.0% | 58.7% | |
| Mar 2026 | $823K USD | -48.1% | +15.3% | 0.5% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 0 SEK | — | — | 0.0% |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -22.0% | +15.3% | 14.0% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.